Related Experiment Videos
The cardiac sarcoplasmic reticulum-glycogenolytic complex. A possible effector site for cyclic AMP
Biochimica Et Biophysica Acta
|September 29, 1977
Summary
This study reveals that cardiac sarcoplasmic reticulum acts as a compartmentalized site for cyclic AMP, influencing both glycogenolysis and calcium transport in heart muscle. This finding highlights a novel regulatory mechanism for cardiac function.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- The sarcoplasmic reticulum (SR) plays a crucial role in cardiac muscle function, primarily in calcium handling.
- The interplay between SR function and cellular metabolism, particularly glycogenolysis, is not fully understood.
Purpose of the Study:
- To investigate the potential role of a cardiac sarcoplasmic reticulum-glycogenolytic complex as a functional unit.
- To determine if this complex serves as a compartmentalized effector site for cyclic AMP (cAMP).
- To elucidate the impact of cAMP on both glycogenolysis and calcium transport within the cardiac SR.
Main Methods:
- Isolation and characterization of a cardiac sarcoplasmic reticulum-glycogenolytic complex using sucrose density gradient centrifugation.
- Assays to measure the conversion of phosphorylase b to a (glycogenolysis marker) and calcium uptake.
- Experiments involving ATP, protein kinase inhibitor, cyclic AMP (cAMP), and adenylate cyclase inhibitor.
Main Results:
- The isolated complex demonstrated modulation of both glycogenolysis and calcium transport.
- ATP stimulated phosphorylase b to a conversion, while protein kinase inhibitor showed inhibition.
- Cyclic AMP alone did not affect phosphorylase conversion or calcium uptake, but reversed inhibition caused by adenylate cyclase inhibitor.
- Endogenous phosphorylation of SR was also regulated by cAMP, suggesting a direct role.
Conclusions:
- The cardiac sarcoplasmic reticulum-glycogenolytic complex functions as an internal effector site for cyclic AMP.
- Cyclic AMP modulates both calcium transport and metabolic processes (glycogenolysis) in cardiac muscle.
- cAMP formation is likely not the rate-limiting step in this activation pathway.